MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to ...

MSD has opened a $1bn facility in Durham located in the US state of North Carolina, to increase vaccine manufacturing ...

MSD's combination of PD-1 inhibitor Keytruda ... as well as colorectal cancer. Neurotech Pharma's cell therapy Encelto has become the first FDA-approved therapy for idiopathic macular ...

Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...

Apollo Cradle and Children’s Hospital in partnership with MSD Pharmaceuticals launched ‘Together for Her Well-being,’ an initiative aimed at empowering women with knowledge about self-care ...

The European Commission (EC) has conditionally approved MSD's Welireg, an oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, as a single agent for the treatment of adults with von Hippel-Lindau ...

Welireg generated $218m in global sales in 2023, as per MSD’s financials, with expectations to reach up to $1.5bn in annual sales in 2030, according to GlobalData’s Pharma Intelligence Center.

Hyderabad: Telangana netted a slew of investments from four multinational players as well as nearly a dozen domestic life sciences players at the inau.

Telangana’s life sciences sector has recorded an impressive 23% growth in recent years, outpacing the national average of 14% ...